Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZKSCAN2 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
mRNA | DRAXIN | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
mRNA | SMIM8 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | EMC4 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-06 |
mRNA | CSRNP2 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
mRNA | FAM57B | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
mRNA | PIAS4 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
mRNA | RBM6 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | ZIC2 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
mRNA | N4BP2 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |